logo

OFIX

Orthofix Medical·NASDAQ
--
--(--)
--
--(--)
1.94 / 10
Underperform

Comprehensive analysis: weak fundamentals (1.9/10). Positive dimensions: Asset-MV and Net profit attributable to parent company shareholders / Net profit (%), although drawbacks are visible in Net income-Revenue and Cash-MV. Resulting position: defensive.

Fundamental(1.94)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value0.86
Score1/3
Weight9.91%
1M Return-1.83%
ROA (%)
Value-10.43
Score2/3
Weight2.31%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.02%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight14.14%
1M Return-2.55%
Cash-UP
Value-0.37
Score2/3
Weight24.42%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-13.90
Score2/3
Weight2.31%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight11.29%
1M Return-1.95%
Asset-MV
Value-0.50
Score2/3
Weight-11.75%
1M Return1.60%
Cash-MV
Value-0.50
Score1/3
Weight26.83%
1M Return-5.64%
Net profit / Total profit (%)
Value101.53
Score2/3
Weight10.52%
1M Return-1.71%
Is OFIX undervalued or overvalued?
  • OFIX scores 1.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -19.03% ROE, -14.56% net margin, -4.26 P/E ratio, 1.15 P/B ratio, and 3.50% earnings growth, these metrics solidify its Underperform investment rating.